Ministers of African national governments, meeting in Nigeria's capitalof Abuja for the first African Summit on HIV/AIDS, Tuberculosis and Other Related Infectious Diseases, have agreed a declaration urging their countries to import and manufacture generic HIV/AIDS drug treatments.
The agreement calls on the 53 member states of the Organization of African Unity to import and produce their own generic drugs, "preferably in partnership with donors and pharmaceutical companies," and for the governments of each member state to ratify the declaration through their legislative chambers, according to Associated Press reports.
The Summit was organized by the Nigerian government, the OAU and the World Health Organization.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze